Avenue Therapeutics, Inc. - Common Stock (ATXI)
1.3600
+0.0400 (3.03%)
Avenue Therapeutics Inc is a pharmaceutical company focused on the development of innovative therapies for the treatment of various medical conditions, primarily within the realm of pain management
The company is dedicated to advancing its pipeline of drug candidates, leveraging scientific research and clinical expertise to address unmet needs in healthcare. Avenue Therapeutics aims to bring new options to patients and healthcare providers, with a commitment to improving quality of life through its therapeutic solutions.
Frequently Asked Questions
Is Avenue Therapeutics, Inc. - Common Stock publicly traded?
Yes, Avenue Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Avenue Therapeutics, Inc. - Common Stock trade on?
Avenue Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Avenue Therapeutics, Inc. - Common Stock?
The ticker symbol for Avenue Therapeutics, Inc. - Common Stock is ATXI on the Nasdaq Stock Market
What is the current price of Avenue Therapeutics, Inc. - Common Stock?
The current price of Avenue Therapeutics, Inc. - Common Stock is 1.360
When was Avenue Therapeutics, Inc. - Common Stock last traded?
The last trade of Avenue Therapeutics, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Avenue Therapeutics, Inc. - Common Stock?
The market capitalization of Avenue Therapeutics, Inc. - Common Stock is 11.13M
How many shares of Avenue Therapeutics, Inc. - Common Stock are outstanding?
Avenue Therapeutics, Inc. - Common Stock has 8.18M shares outstanding.